A randomized placebo-controlled Phase 1 trial in healthy volunteers investigating safety, pharmacokinetics and pharmacodynamics of a novel menin inhibitor, balomenib (ZE63-0302): Interim analysis.
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Amy Burd, Brian Ledwith, Megan Johnstone, Erin Hertlein, Alexander Khvat, Ola Elgamal, Ruben Karapetian, Kate Dokukina, Fraser Pickersgill, Peter Schrader, Nikolay Savchuk, Iain Dukes, John Byrd
Institutions: University of Cincinnati, ChemDiv (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108490125
Cites:
Cited by:
Related to: